116 related articles for article (PubMed ID: 8487058)
1. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
Lee JS; Newman RA; Lippman SM; Huber MH; Minor T; Raber MN; Krakoff IH; Hong WK
J Clin Oncol; 1993 May; 11(5):959-66. PubMed ID: 8487058
[TBL] [Abstract][Full Text] [Related]
2. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
[TBL] [Abstract][Full Text] [Related]
3. Variability in the oral bioavailability of all-trans-retinoic acid.
Adamson PC; Pitot HC; Balis FM; Rubin J; Murphy RF; Poplack DG
J Natl Cancer Inst; 1993 Jun; 85(12):993-6. PubMed ID: 8388479
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
Smith MA; Adamson PC; Balis FM; Feusner J; Aronson L; Murphy RF; Horowitz ME; Reaman G; Hammond GD; Fenton RM
J Clin Oncol; 1992 Nov; 10(11):1666-73. PubMed ID: 1403049
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
[TBL] [Abstract][Full Text] [Related]
8. Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.
Lee JS; Newman RA; Lippman SM; Fossella FV; Calayag M; Raber MN; Krakoff IH; Hong WK
J Clin Oncol; 1995 Jun; 13(6):1501-8. PubMed ID: 7751898
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of 9-cis retinoic acid in adults with solid tumors.
Kurie JM; Lee JS; Griffin T; Lippman SM; Drum P; Thomas MP; Weber C; Bader M; Massimini G; Hong WK
Clin Cancer Res; 1996 Feb; 2(2):287-93. PubMed ID: 9816171
[TBL] [Abstract][Full Text] [Related]
10. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
[TBL] [Abstract][Full Text] [Related]
11. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.
Miller VA; Rigas JR; Benedetti FM; Verret AL; Tong WP; Kris MG; Gill GM; Loewen GR; Truglia JA; Ulm EH; Warrell RP
Clin Cancer Res; 1996 Mar; 2(3):471-5. PubMed ID: 9816192
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.
Conley BA; Egorin MJ; Sridhara R; Finley R; Hemady R; Wu S; Tait NS; Van Echo DA
Cancer Chemother Pharmacol; 1997; 39(4):291-9. PubMed ID: 9025769
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndrome.
Kurzrock R; Estey E; Talpaz M
J Clin Oncol; 1993 Aug; 11(8):1489-95. PubMed ID: 8336187
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.
Schilsky RL; Hohneker J; Ratain MJ; Janisch L; Smetzer L; Lucas VS; Khor SP; Diasio R; Von Hoff DD; Burris HA
J Clin Oncol; 1998 Apr; 16(4):1450-7. PubMed ID: 9552051
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
[TBL] [Abstract][Full Text] [Related]
17. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
18. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.
Calvert AH; Alison DL; Harland SJ; Robinson BA; Jackman AL; Jones TR; Newell DR; Siddik ZH; Wiltshaw E; McElwain TJ
J Clin Oncol; 1986 Aug; 4(8):1245-52. PubMed ID: 3734849
[TBL] [Abstract][Full Text] [Related]
19. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
Li S; Huang H; Liao H; Zhan J; Guo Y; Zou BY; Jiang WQ; Guan ZZ; Yang XQ
Int J Clin Pharmacol Ther; 2013 Feb; 51(2):96-105. PubMed ID: 23127487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
